Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

To assess the long-term effect of 1,25(OH)2 vitamin D on T cell activation, PBMCs from 13 healthy donors were isolated and cultured for 5 days in the absence (CTR) or presence of 1,25(OH)2 vitamin D (10 or 100 nM).

Source: Effect of 1,25(OH)2 vitamin D on IFN-γ production and secretion by PBMCs. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The 1α,25-dihydroxyvitamin D3 modulates T cell activation and immune checkpoint pathways in human T cells

Study design awaiting verification · Frontiers in Immunology · 2026

Original publication title

The 1α,25-dihydroxyvitamin D3 modulates T cell activation and immune checkpoint pathways in human T cells

Lisa Isdraele Romano; Ilenia Aversa; Antonio Abatino; Costanza Maria Cristiani; Giulio Cesare Antico; Debora Gentile; Caterina Giordano; Emilio Straface; Michael Marrano; Elvira Angotti; Camillo Palmieri; Raffaella Gallo; Giuseppe Fiume

Copyright © 2026 Isdraele Romano, Aversa, Abatino, Cristiani, Antico, Gentile, Giordano, Straface, Marrano, Angotti, Palmieri, Gallo and Fiume.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These findings support an immunomodulatory effect of 1,25(OH)2 vitamin D on human CD8+ T cells, with attenuation of effector-associated responses and modulation of checkpoint-associated pathways in vitro. Our results suggest that vitamin D may contribute to the regulation of inflammatory T-cell responses under controlled culture conditions. The functional and therapeutic implications of these observations require further investigation.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Vitamin D is a pleiotropic steroid hormone with immunomodulatory properties. The role of the active metabolite, 1α,25-dihydroxyvitamin D3 (1,25(OH)2 vitamin D), in regulating human T-cell effector function and immune checkpoint (IC) pathways remains poorly defined.

Source: Background

Abstract: What methods does the paper describe?

Peripheral blood mononuclear cells (PBMCs) from healthy donors were cultured for five days in presence or absence of 1,25(OH)2 vitamin D (10 or 100 nM). IFN-γ production was assessed by ELISpot assay. Baseline plasma 1,25(OH)2 vitamin D levels were measured. IC-related gene expression was evaluated by RT-qPCR. Flow cytometry was used to assess the expression of IC, degranulation, and activation markers. FluoroSpot assays were performed to quantify interleukin secretion.

Source: Methods

Abstract: Results

1,25(OH)2 vitamin D reduced IFN-γ expression and secretion independently of baseline circulating 1,25(OH)2 vitamin D levels. Dose-specific modulation of IC genes was detected, with increased PDCD1 and CTLA4 mRNA expression. Flow cytometry showed selective modulation within the CD8+ T-cell compartment, with increased PD-1 expression at 10 nM and increased CTLA-4 expression at 100 nM, together with decreased degranulation and activation markers. No significant changes were detected for TIM-3 or TIGIT. In CD4+ T cells, no significant modulation of IC molecules was observed, whereas IL-22 secretion was reduced.

Source: Results

Abstract: Conclusions

These findings support an immunomodulatory effect of 1,25(OH)2 vitamin D on human CD8+ T cells, with attenuation of effector-associated responses and modulation of checkpoint-associated pathways in vitro. Our results suggest that vitamin D may contribute to the regulation of inflammatory T-cell responses under controlled culture conditions. The functional and therapeutic implications of these observations require further investigation.

Source: Conclusions
Authors’ abstract

Background

Vitamin D is a pleiotropic steroid hormone with immunomodulatory properties. The role of the active metabolite, 1α,25-dihydroxyvitamin D3 (1,25(OH)2 vitamin D), in regulating human T-cell effector function and immune checkpoint (IC) pathways remains poorly defined.

Methods

Peripheral blood mononuclear cells (PBMCs) from healthy donors were cultured for five days in presence or absence of 1,25(OH)2 vitamin D (10 or 100 nM). IFN-γ production was assessed by ELISpot assay. Baseline plasma 1,25(OH)2 vitamin D levels were measured. IC-related gene expression was evaluated by RT-qPCR. Flow cytometry was used to assess the expression of IC, degranulation, and activation markers. FluoroSpot assays were performed to quantify interleukin secretion.

Results

1,25(OH)2 vitamin D reduced IFN-γ expression and secretion independently of baseline circulating 1,25(OH)2 vitamin D levels. Dose-specific modulation of IC genes was detected, with increased PDCD1 and CTLA4 mRNA expression. Flow cytometry showed selective modulation within the CD8+ T-cell compartment, with increased PD-1 expression at 10 nM and increased CTLA-4 expression at 100 nM, together with decreased degranulation and activation markers. No significant changes were detected for TIM-3 or TIGIT. In CD4+ T cells, no significant modulation of IC molecules was observed, whereas IL-22 secretion was reduced.

Conclusions

These findings support an immunomodulatory effect of 1,25(OH)2 vitamin D on human CD8+ T cells, with attenuation of effector-associated responses and modulation of checkpoint-associated pathways in vitro. Our results suggest that vitamin D may contribute to the regulation of inflammatory T-cell responses under controlled culture conditions. The functional and therapeutic implications of these observations require further investigation.

Publication and source details

Original title: The 1α,25-dihydroxyvitamin D3 modulates T cell activation and immune checkpoint pathways in human T cells

Lisa Isdraele Romano; Ilenia Aversa; Antonio Abatino; Costanza Maria Cristiani; Giulio Cesare Antico; Debora Gentile; Caterina Giordano; Emilio Straface; Michael Marrano; Elvira Angotti; Camillo Palmieri; Raffaella Gallo; Giuseppe Fiume

Frontiers in Immunology · 2026

* Correspondence: Camillo Palmieri, cpalmieri@unicz.it; Raffaella Gallo, r.gallo@unicz.it

†These authors have contributed equally to this work

‡These authors share last authorship

Copyright © 2026 Isdraele Romano, Aversa, Abatino, Cristiani, Antico, Gentile, Giordano, Straface, Marrano, Angotti, Palmieri, Gallo and Fiume.2026Isdraele Romano, Aversa, Abatino, Cristiani, Antico, Gentile, Giordano, Straface, Marrano, Angotti, Palmieri, Gallo and Fiumehttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Regione Calabria10.13039/501100009877 FESR-FSE 2014-2020 “SAGGIO PER IL DOSAGGIO DELLA PROTEINA PD-L1 IN CAMPIONI BIOLOGICI”, RF-2019-12370255, “Identification and validation of biomarkers to predict response to immunotherapy in endometrial cancer” Ministero dell’Istruzione, dell’Università e della Ricerca10.13039/501100003407 PNRR “HEAL ITALIA: Health Extended ALliance for Innovative Therapies, Advanced Labresearch, and Integrated Approaches of Precision Medicine”The author(s) declared that financial support was received for this work and/or its publication. This work was supported by Regione Calabria FESR-FSE 2014-2020 “SAGGIO PER IL DOSAGGIO DELLA PROTEINA PD-L1 IN CAMPIONI BIOLOGICI”, and RF-2019-12370255, “Identification and validation of biomarkers to predict response to immunotherapy in endometrial cancer” to CP; by Ministero dell’Istruzione, dell’Università e della Ricerca (Ministry of Education, University and Research): FFARB and by Università Milano Bicocca, PNRR “HEAL ITALIA: Health Extended ALliance for Innovative Therapies, Advanced Labresearch, and Integrated Approaches of Precision Medicine” to GF.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:09:15.169540+00:00

DOI: 10.3389/fimmu.2026.1802168 · PMC13391584